Israel's Compugen Releases New Medical Treatment Systems and NeuroSense Sells $4.5 Million in shares

NeuroSense entered into a securities purchase agreement with a single health-care focused investor for 3,000,000 ordinary shares

Related Keywords

Israel ,Israeli ,Shiran Zimri ,Edmund Benami ,Micha Breakstone ,Gil Shklarski ,Flatiron Health ,Neurosense Therapeutics Ltd ,Compugen Ltd ,Compugen ,Oncology Congress ,Scientific Programs ,Sense Therapeutics ,Business News ,Jewish Business News ,Anat Cohen Dayag ,Neurosense Therapeutics ,